Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,790 | 6 | 61.2% |
| Travel and Lodging | $7,290 | 6 | 21.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,550 | 3 | 16.3% |
| Food and Beverage | $342.04 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hexal AG | $22,145 | 14 | $0 (2020) |
| IBSA Institut Biochimique SA | $8,750 | 2 | $0 (2023) |
| VistaPharm, Inc. | $1,540 | 1 | $0 (2021) |
| IBSA Pharma Inc. | $1,538 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,250 | 1 | IBSA Institut Biochimique SA ($1,250) |
| 2021 | $9,040 | 2 | IBSA Institut Biochimique SA ($7,500) |
| 2020 | $9,128 | 4 | Hexal AG ($7,628) |
| 2019 | $14,554 | 12 | Hexal AG ($14,517) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2023 | IBSA Institut Biochimique SA | Tirosint (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Endocrinology | ||||||
| 12/22/2021 | VistaPharm, Inc. | Thyquidity (Drug) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Hypothyroidism | ||||||
| 02/26/2021 | IBSA Institut Biochimique SA | Tirosint (Drug) | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: Endocrinology | ||||||
| 04/06/2020 | IBSA Pharma Inc. | Tirosint (Drug), Tirosint | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Endocrinology | ||||||
| 01/07/2020 | Hexal AG | Omnitrope (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Endocrinology | ||||||
| 01/07/2020 | Hexal AG | Omnitrope (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Endocrinology | ||||||
| 01/07/2020 | Hexal AG | Omnitrope (Drug) | Travel and Lodging | Cash or cash equivalent | $128.00 | General |
| Category: Endocrinology | ||||||
| 11/01/2019 | IBSA Pharma Inc. | Tirosint (Drug), Tirosint-SOL | Food and Beverage | In-kind items and services | $37.73 | General |
| Category: Endocrinology | ||||||
| 09/21/2019 | Hexal AG | Omnitrope (Drug) | Travel and Lodging | Cash or cash equivalent | $774.56 | General |
| Category: Endocrinology | ||||||
| 09/21/2019 | Hexal AG | Omnitrope (Drug) | Food and Beverage | Cash or cash equivalent | $49.65 | General |
| Category: Endocrinology | ||||||
| 09/20/2019 | Hexal AG | Omnitrope (Drug) | Food and Beverage | Cash or cash equivalent | $154.66 | General |
| Category: Endocrinology | ||||||
| 09/19/2019 | Hexal AG | Omnitrope (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,049.92 | General |
| Category: Endocrinology | ||||||
| 08/15/2019 | Hexal AG | Omnitrope (Drug) | Travel and Lodging | Cash or cash equivalent | $5,338.63 | General |
| Category: Endocrinology | ||||||
| 04/16/2019 | Hexal AG | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 04/16/2019 | Hexal AG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 04/16/2019 | Hexal AG | — | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| 03/27/2019 | Hexal AG | — | Travel and Lodging | Cash or cash equivalent | $747.14 | General |
| 03/27/2019 | Hexal AG | — | Travel and Lodging | Cash or cash equivalent | $242.14 | General |
| 03/27/2019 | Hexal AG | — | Food and Beverage | Cash or cash equivalent | $100.00 | General |
About Dr. Andrew Bauer, M.D
Dr. Andrew Bauer, M.D is a Pediatric Endocrinology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992748974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Bauer, M.D has received a total of $33,972 in payments from pharmaceutical and medical device companies, with $1,250 received in 2023. These payments were reported across 19 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($20,790).
Practice Information
- Specialty Pediatric Endocrinology
- Location Philadelphia, PA
- Active Since 06/14/2006
- Last Updated 04/15/2013
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1992748974
Products in Payments
- Omnitrope (Drug) $14,995
- Tirosint (Drug) $10,288
- Thyquidity (Drug) $1,540
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Philadelphia
Maria Vogiatzi, Md, MD
Pediatric Endocrinology — Payments: $350,818
Dr. Judith Ross, Md, MD
Pediatric Endocrinology — Payments: $138,423
Dr. Jake Kushner, M.d, M.D
Pediatric Endocrinology — Payments: $72,214
Dr. David Weber, Md, MD
Pediatric Endocrinology — Payments: $18,757
Vaneeta Bamba, Md, MD
Pediatric Endocrinology — Payments: $11,068
Rachana Shah, M.d, M.D
Pediatric Endocrinology — Payments: $3,517